Literature DB >> 24455475

Insulin resistance and incident heart failure the ARIC study (Atherosclerosis Risk in Communities).

Orly Vardeny, Deepak K Gupta, Brian Claggett, Stuart Burke, Amil Shah, Laura Loehr, Laura Rasmussen-Torvik, Elizabeth Selvin, Patricia P Chang, David Aguilar, Scott D Solomon.   

Abstract

OBJECTIVES: This study was designed to assess the relationship between insulin resistance and incident heart failure (HF) in a community-based cohort.
BACKGROUND: Diabetes mellitus increases the risk for HF, but the association between insulin resistance and HF in individuals without diabetes is unclear.
METHODS: We prospectively analyzed 12,606 participants without diabetes mellitus, prevalent HF, or history of myocardial infarction at baseline (1987 to 1989) from the ARIC (Atherosclerosis Risk in Communities) study. We assessed the relationship between insulin resistance and incident HF using the homeostatic model assessment of insulin resistance (HOMA-IR) equation, adjusting for age, sex, race, body mass index, smoking, hypertension, center, and interim myocardial infarction. We tested for interactions by age, sex, obesity, and race.
RESULTS: Participants with insulin resistance, defined as HOMA-IR ≥2.5 (n = 4,810, 39%), were older, more likely female, African American, hypertensive, and had a higher body mass index as compared with those without insulin resistance. There were 1,455 incident HF cases during a median of 20.6 years of follow-up. Insulin resistance defined by this threshold was not significantly associated with an increased risk for incident HF after adjustment (hazard ratio: 1.08, 95% confidence interval: 0.95 to 1.23). However, when analyzed continuously, this relationship was nonlinear, which indicated that risk increased, and was significantly associated with incident HF between HOMA-IR of 1.0 to 2.0, adjusting for baseline covariates; however, values over 2.5 were not associated with additional increased risk in adjusted models.
CONCLUSIONS: In a community cohort, insulin resistance, defined by lower levels of HOMA-IR than previously considered, was associated with an increased risk for HF.

Entities:  

Mesh:

Year:  2013        PMID: 24455475      PMCID: PMC3893700          DOI: 10.1016/j.jchf.2013.07.006

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  24 in total

1.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

Authors:  J He; L G Ogden; L A Bazzano; S Vupputuri; C Loria; P K Whelton
Journal:  Arch Intern Med       Date:  2001-04-09

2.  Glycemic control and heart failure among adult patients with diabetes.

Authors:  C Iribarren; A J Karter; A S Go; A Ferrara; J Y Liu; S Sidney; J V Selby
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

3.  Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men.

Authors:  J Sundström; L Lind; N Nyström; B Zethelius; B Andrén; C N Hales; H O Lithell
Journal:  Circulation       Date:  2000-06-06       Impact factor: 29.690

4.  Impact of diabetes on cardiac structure and function: the strong heart study.

Authors:  R B Devereux; M J Roman; M Paranicas; M J O'Grady; E T Lee; T K Welty; R R Fabsitz; D Robbins; E R Rhoades; B V Howard
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

5.  Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study.

Authors:  Martin K Rutter; Helen Parise; Emelia J Benjamin; Daniel Levy; Martin G Larson; James B Meigs; Richard W Nesto; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

6.  Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism.

Authors:  Juan F Ascaso; Susana Pardo; José T Real; Rosario I Lorente; Antonia Priego; Rafael Carmena
Journal:  Diabetes Care       Date:  2003-12       Impact factor: 19.112

7.  Effects of angiotensin II and insulin on ERK1/2 activation in fibroblasts from hypertensive patients.

Authors:  Michelangelo Sartori; Giulio Ceolotto; Italia Papparella; Elisabetta Baritono; Laura Ciccariello; Lorenzo Calò; Matteo Leoni; Andrea Semplicini
Journal:  Am J Hypertens       Date:  2004-07       Impact factor: 2.689

8.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

9.  Insulin resistance and risk of incident heart failure: Cardiovascular Health Study.

Authors:  Dipanjan Banerjee; Mary L Biggs; Laina Mercer; Kenneth Mukamal; Robert Kaplan; Joshua Barzilay; Lewis Kuller; Jorge R Kizer; Luc Djousse; Russell Tracy; Susan Zieman; Donald Lloyd-Jones; David Siscovick; Mercedes Carnethon
Journal:  Circ Heart Fail       Date:  2013-04-10       Impact factor: 8.790

10.  Obesity and the risk of heart failure.

Authors:  Satish Kenchaiah; Jane C Evans; Daniel Levy; Peter W F Wilson; Emelia J Benjamin; Martin G Larson; William B Kannel; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-08-01       Impact factor: 91.245

View more
  34 in total

1.  Depressive symptoms and spiritual wellbeing in asymptomatic heart failure patients.

Authors:  Paul J Mills; Kathleen Wilson; Navaid Iqbal; Fatima Iqbal; Milagros Alvarez; Meredith A Pung; Katherine Wachmann; Thomas Rutledge; Jeanne Maglione; Sid Zisook; Joel E Dimsdale; Ottar Lunde; Barry H Greenberg; Alan Maisel; Ajit Raisinghani; Loki Natarajan; Shamini Jain; David J Hufford; Laura Redwine
Journal:  J Behav Med       Date:  2014-12-23

2.  Branched-Chain Amino Acid Metabolism in the Failing Heart.

Authors:  Qutuba G Karwi; Gary D Lopaschuk
Journal:  Cardiovasc Drugs Ther       Date:  2022-02-12       Impact factor: 3.727

Review 3.  Cardiometabolic-based chronic disease: adiposity and dysglycemia drivers of heart failure.

Authors:  Eduardo Thadeu de Oliveira Correia; Jeffrey I Mechanick; Letícia Mara Dos Santos Barbetta; Antonio José Lagoeiro Jorge; Evandro Tinoco Mesquita
Journal:  Heart Fail Rev       Date:  2022-04-04       Impact factor: 4.214

Review 4.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

5.  Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity.

Authors:  Brian Bostick; Javad Habibi; Lixin Ma; Annayya Aroor; Nathan Rehmer; Melvin R Hayden; James R Sowers
Journal:  Metabolism       Date:  2014-04-12       Impact factor: 8.694

Review 6.  Insulin resistance and heart failure during treatment with sodium glucose cotransporter 2 inhibitors: proposed role of ketone utilization.

Authors:  Yoshiyuki Hattori
Journal:  Heart Fail Rev       Date:  2020-05       Impact factor: 4.214

7.  The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF.

Authors:  Nazir Savji; Wouter C Meijers; Traci M Bartz; Vijeta Bhambhani; Mary Cushman; Matthew Nayor; Jorge R Kizer; Amy Sarma; Michael J Blaha; Ron T Gansevoort; Julius M Gardin; Hans L Hillege; Fei Ji; Willem J Kop; Emily S Lau; Douglas S Lee; Ruslan Sadreyev; Wiek H van Gilst; Thomas J Wang; Markella V Zanni; Ramachandran S Vasan; Norrina B Allen; Bruce M Psaty; Pim van der Harst; Daniel Levy; Martin Larson; Sanjiv J Shah; Rudolf A de Boer; John S Gottdiener; Jennifer E Ho
Journal:  JACC Heart Fail       Date:  2018-07-11       Impact factor: 12.035

8.  Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score.

Authors:  Ankit Maheshwari; Faye L Norby; Nicholas S Roetker; Elsayed Z Soliman; Ryan J Koene; Mary R Rooney; Wesley T O'Neal; Amil M Shah; Brian L Claggett; Scott D Solomon; Alvaro Alonso; Rebecca F Gottesman; Susan R Heckbert; Lin Y Chen
Journal:  Circulation       Date:  2019-01-08       Impact factor: 29.690

Review 9.  Cardiac Energy Metabolism in Heart Failure.

Authors:  Gary D Lopaschuk; Qutuba G Karwi; Rong Tian; Adam R Wende; E Dale Abel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

10.  Impact of Acute Insulin Resistance on Myocardial Blush in Non-Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Soheir M Kasem; Ghada Mohamed Saied; Abdel Nasser Ma Hegazy; Mahmoud Abdelsabour
Journal:  Front Cardiovasc Med       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.